Cannabinoid receptor-2 has shown therapeutic potential as a target against HAND and other CNS disorders, such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), Parkinson’s disease (PD), multiple sclerosis (MS), Huntington’s disease (HD), neuropathic pain, and migraine [24]. Here, CNR2 is linked to Alzheimer disease.